Stockholders’ Equity and Equity Incentive Plans (Tables)

9 Months Ended

Oct. 31, 2024

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity Under Equity Incentive Plan

A summary of stock option activity under our equity incentive plan and related information is as follows:

	Stock Options
	Outstanding Stock Options	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (Years)	Aggregate Intrinsic Value
	(in thousands, except share, life, and per share data)
Balance as of January 31, 2024	3,314,228	$	8.21	3.9	$	189,921
Exercised	(485,133)	$	7.73		$	28,025
Canceled/forfeited/expired	(6,188)	$	92.67
Outstanding and exercisable as of October 31, 2024	2,822,907	$	8.11	3.1	$	189,950

Schedule of Restricted Stock Units (RSUs) Activity Under Equity Incentive Plan

A summary of RSU activity under our equity incentive plan and related information is as follows:

	RSUs
	RSUs	Weighted- Average Grant Date Fair Value Per Share
Unvested as of January 31, 2024	26,040,557	$	83.14
Granted	11,373,214	$	64.22
Vested	(9,521,433)	$	86.00
Canceled/forfeited	(2,968,603)	$	78.52
Unvested as of October 31, 2024	24,923,735	$	73.97

Schedule of Stock-Based Compensation Expense by Line Item

The stock-based compensation expense by line item in the accompanying condensed consolidated statements of operations is summarized as follows:

	Three Months Ended October 31,				Nine Months Ended October 31,
	2024		2023		2024		2023
	(in thousands)
Cost of revenue	$	30,439	$	35,514	$	93,313	$	111,138
Research and development	89,836		86,662		254,002		250,165
Sales and marketing	80,738		86,593		242,197		293,104
General and administrative	39,982		50,165		118,858		148,381
Total stock-based compensation expense	$	240,995	$	258,934	$	708,370	$	802,788
Benefit from income taxes	(44,279)		(48,646)		(131,495)		(147,089)
Total stock-based compensation expense recorded to net income	$	196,716	$	210,288	$	576,875	$	655,699